AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16171664 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg oral rofecoxib preoperatively with IV placebo injection
Number of subjects: 54
Study 16171664 — intervention group
Group type: COMPARATOR
Intervention: 30 mg IV ketorolac preoperatively with placebo
Number of subjects: 54
Study 12576891 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronous ligation with the new anoscope
Number of subjects: 50
Study 12576891 — intervention group
Group type: COMPARATOR
Intervention: Conventional ligation with a conventional anoscope
Number of subjects: 50
Study 10573501 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual chamber pacing (DDD)
Number of subjects: 12
Study 10573501 — intervention group
Group type: EXPERIMENTAL
Intervention: Single chamber ventricular pacing (VVI)
Number of subjects: 12
Study 11322256 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (500 mg daily or 750 mg daily depending on weight)
Number of subjects: 356
Study 11322256 — intervention group
Group type: COMPARATOR
Intervention: Zidovudine (600 mg daily)
Number of subjects: 356
Study 11322256 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (low-dose)
Number of subjects: 356
Study 11322256 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (high-dose)
Number of subjects: 356
Study 1908745 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular Ig 25 mg/kg/wk
Number of subjects: 43
Study 1908745 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular Ig 50 mg/kg/wk
Number of subjects: 43
Study 1908745 — intervention group
Group type: COMPARATOR
Intervention: Saline injections
Number of subjects: 43
Study 6809420 — intervention group
Group type: EXPERIMENTAL
Intervention: Levonorgestrel-releasing IUDs
Number of subjects: 0
Study 6809420 — intervention group
Group type: COMPARATOR
Intervention: Nova-T copper device
Number of subjects: 0
Study 31842388 — intervention group
Group type: EXPERIMENTAL
Intervention: Stevia (1 g)
Number of subjects: 30
Study 31842388 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 30
Study 31842388 — intervention group
Group type: COMPARATOR
Intervention: Sugar (60 g)
Number of subjects: 30
Study 30012318 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAID use
Number of subjects: 18113
Study 25824193 — intervention group
Group type: EXPERIMENTAL
Intervention: CT angiography (CTA)
Number of subjects: 63
Study 25824193 — intervention group
Group type: COMPARATOR
Intervention: Doppler ultrasound (US)
Number of subjects: 63
Study 24165361 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxillary osteotomy in CLP group
Number of subjects: 20
Study 24165361 — intervention group
Group type: COMPARATOR
Intervention: Non-cleft control group (NonCLP)
Number of subjects: 20
Study 19825903 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg pregabalin
Number of subjects: 40
Study 19825903 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 19700435 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab treatment
Number of subjects: 0
Study 19700435 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-treatment colonic mucosal gene expression profiles
Number of subjects: 0
Study 17005066 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Stimulation Therapy (CST) combined with 5 mg of donepezil per day for one year.
Number of subjects: 30
Study 17005066 — intervention group
Group type: COMPARATOR
Intervention: 5 mg of donepezil per day (control group).
Number of subjects: 30
Study 15075418 — intervention group
Group type: EXPERIMENTAL
Intervention: Facility-based multiple-component training program followed by home-based adherence
Number of subjects: 150
Study 15075418 — intervention group
Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 150
Study 11161371 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumpectomy followed by radiotherapy (XRT group)
Number of subjects: 152
Study 11161371 — intervention group
Group type: COMPARATOR
Intervention: Lumpectomy alone (no-XRT group)
Number of subjects: 152
Study 9448551 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved glycemic control
Number of subjects: 0
Study 8557061 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine (4 g with a liquid meal)
Number of subjects: 27
Study 8557061 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholestyramine (4 g every 2 days for 1 month)
Number of subjects: 27
Study 8557061 — intervention group
Group type: COMPARATOR
Intervention: Liquid meal (two egg yolks plus water 200 mL, 50 kJ)
Number of subjects: 27
Study 1973768 — intervention group
Group type: EXPERIMENTAL
Intervention: L-thyroxine (T4, 2.5 micrograms/kg body weight daily)
Number of subjects: 78
Study 1973768 — intervention group
Group type: EXPERIMENTAL
Intervention: L-thyroxine (T4, 2.5 micrograms/kg body weight daily) + carbimazole (CBZ, 40 mg daily)
Number of subjects: 78
Study 1973768 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 924705 — intervention group
Group type: EXPERIMENTAL
Intervention: solufenum
Number of subjects: 5
Study 924705 — intervention group
Group type: COMPARATOR
Intervention: ibuprofen
Number of subjects: 5
Study 30281552 — intervention group
Group type: EXPERIMENTAL
Intervention: Albuterol
Number of subjects: 0
Study 30281552 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral corticosteroids
Number of subjects: 0
Study 30281552 — intervention group
Group type: COMPARATOR
Intervention: Willingness to enroll in RCT
Number of subjects: 0
Study 31490964 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive social marketing intervention
Number of subjects: 10
Study 31490964 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intensive intervention)
Number of subjects: 10
Study 26242287 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure at UB60 and K3 points for 3 minutes before heel prick
Number of subjects: 32
Study 26242287 — intervention group
Group type: COMPARATOR
Intervention: Control group (no acupressure)
Number of subjects: 32
Study 23753039 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-patient navigation
Number of subjects: 350
Study 23753039 — intervention group
Group type: EXPERIMENTAL
Intervention: Pro-patient navigation
Number of subjects: 350
Study 23753039 — intervention group
Group type: COMPARATOR
Intervention: Standard navigation
Number of subjects: 350
Study 22208800 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation strategy (including training session, information distribution, opinion leader) of a breastfeeding guideline in primary care
Number of subjects: 240
Study 22208800 — intervention group
Group type: COMPARATOR
Intervention: Usual diffusion
Number of subjects: 240
Study 19114187 — intervention group
Group type: EXPERIMENTAL
Intervention: Reconstituted fresh whole blood
Number of subjects: 64
Study 19114187 — intervention group
Group type: COMPARATOR
Intervention: Standard blood component therapy
Number of subjects: 64
Study 16571129 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexitouch
Number of subjects: 10
Study 16571129 — intervention group
Group type: COMPARATOR
Intervention: Massage
Number of subjects: 10
Study 16571129 — intervention group
Group type: COMPARATOR
Intervention: Flexitouch and Massage
Number of subjects: 10
Study 12616206 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser ablation
Number of subjects: 135
Study 12616206 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial turbinectomy (PT)
Number of subjects: 135
Study 12616206 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency tissue ablation
Number of subjects: 135
Study 12616206 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 135
Study 12616206 — intervention group
Group type: EXPERIMENTAL
Intervention: Rhinomanometric measurements
Number of subjects: 135
Study 10675166 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic-floor re-education programme for up to 1 year
Number of subjects: 102
Study 10675166 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy (control group)
Number of subjects: 102
Study 10675166 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic-floor re-education
Number of subjects: 102
Study 8814201 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (35 mg 20:5(n‐3) + 22:6(n‐3)/(kg body weight.d))
Number of subjects: 26
Study 8814201 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed oil (35 mg 18:3(n‐3)/(kg body weight.d))
Number of subjects: 26
Study 8814201 — intervention group
Group type: COMPARATOR
Intervention: Olive oil (35 mg 18:1/(kg body weight.d))
Number of subjects: 26
Study 8814201 — intervention group
Group type: EXPERIMENTAL
Intervention: All oil treatments
Number of subjects: 26
Study 8814201 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil and olive oil supplementation
Number of subjects: 26
Study 1728671 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiography
Number of subjects: 20
Study 1728671 — intervention group
Group type: EXPERIMENTAL
Intervention: Duplex scanning
Number of subjects: 20
Study 1728671 — intervention group
Group type: EXPERIMENTAL
Intervention: Angioscopy
Number of subjects: 20
Study 6368906 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte transfusions plus antibiotic therapy (IFCL & CFCL group)
Number of subjects: 75
Study 6368906 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte transfusions plus antibiotic therapy (FL group)
Number of subjects: 75
Study 6368906 — intervention group
Group type: COMPARATOR
Intervention: Antibiotic therapy alone (control group)
Number of subjects: 75
Study 6368906 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte transfusions plus antibiotic therapy (all transfused patients)
Number of subjects: 75
Study 31509182 — intervention group
Group type: EXPERIMENTAL
Intervention: 200/50 mg dispersible levodopa/benserazide
Number of subjects: 34
Study 31509182 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 30071909 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention (GET.ON M.E.D.)
Number of subjects: 260
Study 30071909 — intervention group
Group type: COMPARATOR
Intervention: Active control group receiving web-based psychoeducation
Number of subjects: 260
Study 26052813 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of daily topical antioxidant hydrogel plus excimer light (Group A)
Number of subjects: 30
Study 26052813 — intervention group
Group type: COMPARATOR
Intervention: Excimer light alone (Group B)
Number of subjects: 30
Study 24774442 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal prasterone (DHEA) 0, 3.25 mg, 6.5 mg or 13 mg daily for 12 weeks
Number of subjects: 215
Study 24774442 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal prasterone (DHEA) in the MSD+ group
Number of subjects: 215
Study 24774442 — intervention group
Group type: COMPARATOR
Intervention: Intravaginal prasterone (DHEA) in the MSD- group
Number of subjects: 215
Study 22815298 — intervention group
Group type: EXPERIMENTAL
Intervention: CLP (closed-loop control plus 30-μg premeal injections of pramlintide)
Number of subjects: 8
Study 22815298 — intervention group
Group type: COMPARATOR
Intervention: CL (closed-loop control alone)
Number of subjects: 8
Study 20051276 — intervention group
Group type: EXPERIMENTAL
Intervention: AMA1-C1 vaccine (5 microg)
Number of subjects: 24
Study 20051276 — intervention group
Group type: EXPERIMENTAL
Intervention: AMA1-C1 vaccine (20 microg)
Number of subjects: 24
Study 20051276 — intervention group
Group type: EXPERIMENTAL
Intervention: AMA1-C1 vaccine (80 microg)
Number of subjects: 24
Study 20051276 — intervention group
Group type: EXPERIMENTAL
Intervention: AMA1-C1 vaccine (5 microg and 20 microg)
Number of subjects: 24
Study 18173921 — intervention group
Group type: EXPERIMENTAL
Intervention: Carriage of TNFRII R variant
Number of subjects: 467
Study 18173921 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype distribution of PAI-1
Number of subjects: 467
Study 18173921 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined carriage of TNFRII 196R variant and Beta-fibrinogen-455A
Number of subjects: 467
Study 18173921 — intervention group
Group type: EXPERIMENTAL
Intervention: FXIIIA genotypes
Number of subjects: 467
Study 15766428 — intervention group
Group type: EXPERIMENTAL
Intervention: Subtalar sling ankle taping
Number of subjects: 0
Study 15766428 — intervention group
Group type: COMPARATOR
Intervention: Gibney ankle taping procedure
Number of subjects: 0
Study 11914055 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (education about osteoporosis, forearm bone densitometry)
Number of subjects: 0
Study 11914055 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (education about osteoporosis)
Number of subjects: 0
Study 11914055 — intervention group
Group type: COMPARATOR
Intervention: Control group (questionnaire only)
Number of subjects: 0
Study 9809757 — intervention group
Group type: EXPERIMENTAL
Intervention: Low resiliency sole material
Number of subjects: 60
Study 9809757 — intervention group
Group type: COMPARATOR
Intervention: High resiliency sole material
Number of subjects: 60
Study 9809757 — intervention group
Group type: COMPARATOR
Intervention: All interfaces
Number of subjects: 60
Study 7622915 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 1200 mg/day
Number of subjects: 39
Study 7622915 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 1600 mg/day
Number of subjects: 39
Study 7622915 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole 2000 mg/day
Number of subjects: 39
Study 7622915 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluconazole (all dosages)
Number of subjects: 39
Study 2142394 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg medroxyprogesterone acetate (MPA) twice weekly for 3 months
Number of subjects: 274
Study 2142394 — intervention group
Group type: COMPARATOR
Intervention: Abrasio only
Number of subjects: 274
Study 423112 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone interview
Number of subjects: 60
Study 423112 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal interview and capsule count
Number of subjects: 60
Study 423112 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 30946262 — intervention group
Group type: EXPERIMENTAL
Intervention: PTSR test
Number of subjects: 12
Study 30946262 — intervention group
Group type: COMPARATOR
Intervention: WAnT
Number of subjects: 12
Study 31090115 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05 Hz oscillatory profile
Number of subjects: 14
Study 31090115 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 Hz oscillatory profile
Number of subjects: 14
Study 31090115 — intervention group
Group type: COMPARATOR
Intervention: 0 Hz non-oscillatory profile
Number of subjects: 14
Study 27418573 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound
Number of subjects: 10
Study 27418573 — intervention group
Group type: COMPARATOR
Intervention: MRI
Number of subjects: 10
Study 27418573 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of ultrasound and MRI
Number of subjects: 10
Study 25773309 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial weight bearing beginning the same day of conservative treatment (Group 1)
Number of subjects: 47
Study 25773309 — intervention group
Group type: COMPARATOR
Intervention: Non-weight bearing after a 4-week period (Group 2)
Number of subjects: 47
Study 23643598 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational video
Number of subjects: 40
Study 23643598 — intervention group
Group type: COMPARATOR
Intervention: Manufacturer video
Number of subjects: 40
Study 21455611 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV) at low amplitude (4 mm peak to peak)
Number of subjects: 18
Study 21455611 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV) at high amplitude (8 mm peak to peak)
Number of subjects: 18
Study 21455611 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole body vibration (WBV)
Number of subjects: 18
Study 19592223 — intervention group
Group type: EXPERIMENTAL
Intervention: VLCD-450 (450 kcal/d)
Number of subjects: 132
Study 19592223 — intervention group
Group type: EXPERIMENTAL
Intervention: VLCD-800 (800 kcal/d)
Number of subjects: 132
Study 17479256 — intervention group
Group type: EXPERIMENTAL
Intervention: alpha‐human ANP (0.05 microg/kg per minute)
Number of subjects: 16
Study 17479256 — intervention group
Group type: COMPARATOR
Intervention: BNP (0.01 microg/kg per minute)
Number of subjects: 16
Study 15011749 — intervention group
Group type: EXPERIMENTAL
Intervention: Elevated vaginal npIGFBP‐1
Number of subjects: 473
Study 15011749 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjusted for covariates
Number of subjects: 473
Study 15011749 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol consumption
Number of subjects: 473
Study 11526473 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvoxamine 300 mg
Number of subjects: 217
Study 11526473 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 217
Study 11526473 — intervention group
Group type: COMPARATOR
Intervention: Pindolol
Number of subjects: 217
Study 9144047 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% minocycline gel
Number of subjects: 30
Study 9144047 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 30
Study 7965549 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclosporine A (CsA)
Number of subjects: 90
Study 7965549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 2447664 — intervention group
Group type: EXPERIMENTAL
Intervention: Iloprost (ZK 36374)
Number of subjects: 0
Study 2447664 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31453941 — intervention group
Group type: EXPERIMENTAL
Intervention: High-load training (80% 1RM)
Number of subjects: 25
Study 31453941 — intervention group
Group type: COMPARATOR
Intervention: Low-load training (30% 1RM)
Number of subjects: 25
Study 31974557 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 36907
Study 31974557 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 36907
Study 30079613 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency endodontic treatment
Number of subjects: 23
Study 30079613 — intervention group
Group type: EXPERIMENTAL
Intervention: STAI‐Trait/State assessment
Number of subjects: 23
Study 30079613 — intervention group
Group type: EXPERIMENTAL
Intervention: NRS scale for anxiety
Number of subjects: 23
Study 30079613 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group discussions
Number of subjects: 23
Study 28589669 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent self-management intervention (MCI)
Number of subjects: 102
Study 28589669 — intervention group
Group type: COMPARATOR
Intervention: Care as usual (CAU)
Number of subjects: 102
Study 25543019 — intervention group
Group type: EXPERIMENTAL
Intervention: Saponin containing extracts
Number of subjects: 23
Study 25543019 — intervention group
Group type: EXPERIMENTAL
Intervention: Soaps made with plant extracts
Number of subjects: 23
Study 25543019 — intervention group
Group type: EXPERIMENTAL
Intervention: Soaps made without plant extracts
Number of subjects: 23
Study 25543019 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 23
Study 25543019 — intervention group
Group type: EXPERIMENTAL
Intervention: Saponin extract applied to Lumbriculus variegatus
Number of subjects: 23
Study 25543019 — intervention group
Group type: EXPERIMENTAL
Intervention: Saponin containing extracts against MCF-7 breast cancer cells
Number of subjects: 23
Study 25543019 — intervention group
Group type: EXPERIMENTAL
Intervention: Saponin containing extracts against HT-29 colon cancer cell lines
Number of subjects: 23
Study 24402627 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomial iron
Number of subjects: 21
Study 24402627 — intervention group
Group type: COMPARATOR
Intervention: Intravenous iron
Number of subjects: 21
Study 20847017 — intervention group
Group type: COMPARATOR
Intervention: Glucosamine
Number of subjects: 3803
Study 20847017 — intervention group
Group type: COMPARATOR
Intervention: Chondroitin
Number of subjects: 3803
Study 20847017 — intervention group
Group type: COMPARATOR
Intervention: Combination of glucosamine and chondroitin
Number of subjects: 3803
Study 20847017 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 3803
Study 18768022 — intervention group
Group type: EXPERIMENTAL
Intervention: Toothpaste
Number of subjects: 6
Study 18768022 — intervention group
Group type: COMPARATOR
Intervention: Acidic soft drinks (lemon juice and SPRITE)
Number of subjects: 6
Study 15913411 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (3 mg)
Number of subjects: 28
Study 15913411 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 12903700 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin flushes (10 U/mL, 1 mL)
Number of subjects: 73
Study 12903700 — intervention group
Group type: COMPARATOR
Intervention: Normal saline flushes (1 mL)
Number of subjects: 73
Study 10475482 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic cardiomyoplasty
Number of subjects: 600
Study 8619362 — intervention group
Group type: EXPERIMENTAL
Intervention: Iobitridol 250 (Xenetix 250)
Number of subjects: 70
Study 8619362 — intervention group
Group type: COMPARATOR
Intervention: iohexol 240 (Omnipaque 240)
Number of subjects: 70
Study 2015168 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinacidil (25 mg, sustained release formulation)
Number of subjects: 6
Study 6794086 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysine-8-vasopressin (LVP) at a dosage starting from 22.5 IU/day to 67.5 IU/day over 3 weeks
Number of subjects: 16
Study 6794086 — intervention group
Group type: EXPERIMENTAL
Intervention: Lysine-8-vasopressin (LVP)
Number of subjects: 16
Study 6794086 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 30639574 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive intramuscular use of 5 mg phenylephrine
Number of subjects: 99
Study 30639574 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive intravenous use of 100 μg phenylephrine
Number of subjects: 99
Study 30639574 — intervention group
Group type: COMPARATOR
Intervention: 0.9% normal saline placebo
Number of subjects: 99
Study 28490464 — intervention group
Group type: EXPERIMENTAL
Intervention: β-adrenergic antagonist (propranolol) and COX-2 inhibitor (etodolac) for 11 days, starting 5 days before surgery
Number of subjects: 38
Study 26264470 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental-shuttle walk test (ISWT)
Number of subjects: 20